Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |